Prawo i regulacje · 24/02/2016

Insys Therapeutics, Inc. Faces DEA Oversight Following Attorney General Delegation

The U.S. Attorney General has delegated her authority under the Controlled Substances Act to the DEA Administrator, effectively giving the agency more control over Insys Therapeutics, Inc.'s bulk manufacturer of controlled substances application.